Plasma therapy is one of the conventional techniques that is majorly used in orthopedic, dentistry and dermatologic specialties. Plasma therapy finds its extensive applications in wound healing, face rejuvenation and androgenetic alopecia. Healing is facilitated when high concentrated plasma, up to 3-5 times of its physiologic value is injected into the patients' tissues.
MARKET DYNAMICS
The plasma therapy market is anticipated to grow in the forecast, owing to rising geriatric population, and increasing demand for minimally invasive therapies. In addition, rising number of patients suffering from orthopedic disorders and androgenic alopecia is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Plasma Therapy Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of plasma therapy market with detailed market segmentation by type, source, application, end user, and geography. The global plasma therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading plasma therapy market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global plasma therapy market is segmented on the basis of by type, source, application, and end user. Based on type, the market is segmented as, pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, leukocyte-rich fibrin. Based on source, the market is segmented in to autologous, and allogenic. On the basis of application, the plasma therapy market is categorized as per orthopedic, dermatology, cardiac muscle injury, dental, nerve injury, and others.
(image)
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global plasma therapy market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The plasma therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting plasma therapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the plasma therapy market in these regions.
(image)
MARKET PLAYERSThe reports cover key developments in the plasma therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from plasma therapy market are anticipated to lucrative growth opportunities in the future with the rising demand for plasma therapy market in the global market. Below mentioned is the list of few companies engaged in the plasma therapy market.
The report also includes the profiles of key plasma therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-Terumo BCT, Inc
-Biolife Plasma Services
-The LFB Group
-Cambryn Biologics
-CSL Limited
-Kedrion S.p.A
-Grifols, S.A.
-Bio Products Laboratory Ltd.
-China Biologic Products Holdings, Inc.
-Octapharma
(image)